Institutional Ownership
Aspire Biopharma Hldgs Inc
CUSIP 738920206COMQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
11
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ubs Group AG | 191.5K | $197.2K |
| 2 | Morgan Stanley | 77.0K | $79.3K |
| 3 | Geode Capital Management, LLC | 43.4K | $44.7K |
| 4 | Crewe Advisors LLC | 20.3K | $20.9K |
| 5 | Toronto Dominion Bank | 5.0K | $5.2K |
| 6 | Tower Research Capital LLC (Trc) | 2.2K | $2.2K |
| 7 | Citigroup Inc | 1.8K | $1.9K |
| 8 | Osaic Holdings, Inc. | 2 | $2 |
| 9 | Avion Wealth | 1.4K | $1 |
| 10 | Sbi Securities Co., Ltd. | 1 | $1 |